Kenvue (KVUE) Stock Price, News & Analysis

Company Overview

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Key Stats

• Today's Range: $22.92 to $23.30
• 50-Day Range: $21.32 to $23.39
• 52-Week Range: $17.67 to $23.55
• Volume: 1.42 million shs
• Average Volume: 18.03 million shs
• Market Capitalization: $44.59 billion
• P/E Ratio: 40.14
• Dividend Yield: 3.52%
• Price Target: $22.64
• Consensus Rating: Hold

Kenvue Stock Analysis - MarketRank™

Kenvue scored higher than 75% of companies evaluated by MarketBeat, and ranked 57th out of 137 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Hold

Consensus Rating

Kenvue has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 4 buy ratings, 7 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Kenvue has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 12.96%

Earnings Growth

Earnings for Kenvue are expected to grow by 12.96% in the coming year, from $1.08 to $1.22 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Kenvue is 39.95, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 126.72.

Price to Earnings Ratio vs. Sector

The P/E ratio of Kenvue is 39.95, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 15.89.

Price to Earnings Growth Ratio

Kenvue has a PEG Ratio of 2.97. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Kenvue has a P/B Ratio of 3.96. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.63% of the float of Kenvue has been sold short.

Short Interest Ratio / Days to Cover

Kenvue has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Kenvue has recently decreased by 31.11%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Kenvue is a leading dividend payer. It pays a dividend yield of 3.61%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Kenvue does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Kenvue is 141.38%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Kenvue will have a dividend payout ratio of 67.21% next year. This indicates that Kenvue will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.63% of the float of Kenvue has been sold short.

Short Interest Ratio / Days to Cover

Kenvue has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Kenvue has recently decreased by 31.11%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.03

News Sentiment

Kenvue has a news sentiment score of 1.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 12 news articles for Kenvue this week, compared to 12 articles on an average week.

Search Interest

20 people have searched for KVUE on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.

MarketBeat Follows

12 people have added Kenvue to their MarketBeat watchlist in the last 30 days. This is an increase of 9% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Kenvue insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.17% of the stock of Kenvue is held by insiders.

Percentage Held by Institutions

97.64% of the stock of Kenvue is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

KVUE Stock Analysis - Frequently Asked Questions

How have KVUE shares performed this year?

Kenvue's stock was trading at $21.53 on January 1st, 2024. Since then, KVUE stock has increased by 7.6% and is now trading at $23.17.
View the best growth stocks for 2024 here.

How were Kenvue's earnings last quarter?

Kenvue Inc. (NYSE:KVUE) released its quarterly earnings results on Tuesday, August, 6th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.28 by $0.04. The business's revenue was down .3% on a year-over-year basis.

When did Kenvue IPO?

Kenvue (KVUE) raised $3.3 billion in an initial public offering (IPO) on Thursday, May 4th 2023. The company issued 151,200,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan, BofA Securities, Citigroup, Deutsche Bank Securities, BNP PARIBAS, HSBC, RBC Capital Markets and UBS Investment Bank served as the underwriters for the IPO.

Who are Kenvue's major shareholders?

Kenvue's top institutional shareholders include Van ECK Associates Corp (1.02%), Yacktman Asset Management LP (0.44%), Sumitomo Mitsui Trust Group Inc. (0.25%) and Raymond James & Associates (0.25%).
View institutional ownership trends.

How do I buy shares of Kenvue?

Shares of KVUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Kenvue own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Kenvue investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH), AUO (AUOTY), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 8/06/2024
• Ex-Dividend for 8/28 Dividend: 8/14/2024
• Dividend Payable: 8/28/2024
• Today: 11/05/2024
• Next Earnings (Confirmed): 11/07/2024
• Ex-Dividend for 11/27 Dividend: 11/13/2024
• Dividend Payable: 11/27/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: Toilet preparations
• Sub-Industry: Consumer Goods
• Current Symbol: NYSE:KVUE
• CUSIP: N/A
• CIK: 1944048
• Web: www.kenvue.com
• Phone: (732) 524-0400
• Fax: N/A
• Employees: 22,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $22.64
• High Stock Price Target: $27.00
• Low Stock Price Target: $18.00
• Potential Upside/Downside: -2.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 12 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.58
• Trailing P/E Ratio: 40.02
• Forward P/E Ratio: 21.49
• P/E Growth: 2.97
• Net Income: $1.66 billion
• Net Margins: 7.23%
• Pretax Margin: 9.27%
• Return on Equity: 21.80%
• Return on Assets: 8.61%

Debt

• Debt-to-Equity Ratio: 0.69
• Current Ratio: 0.99
• Quick Ratio: 0.68

Sales & Book Value

• Annual Sales: $15.44 billion
• Price / Sales: 2.88
• Cash Flow: $1.61 per share
• Price / Cash Flow: 14.46
• Book Value: $5.85 per share
• Price / Book: 3.97

Miscellaneous

• Outstanding Shares: 1,915,170,000
• Free Float: 1,911,911,000
• Market Cap: $44.45 billion
• Optionable: Optionable
• Beta: 1.36